Many drugs now used to treat inflammatory diseases can decrease neutrophil migration and degranulation [12], [13], and we recently showed that neutrophil phenotype is modulated during treatment of RA with anti-TNF therapy, in line with improvements in disease activity [14]. Here, TNF is linked to rheumatoid arthritis.